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In the case of Parkinson’s disease (PD), epidemiological studies have reported that
pesticide exposure is a risk factor for its pathology. It has been suggested that
some chemical agents, such as rotenone and paraquat, that inhibit the mitochondrial
respiratory chain (in the same way as the PD mimetic toxin 1-methyl-4-phenylpyridinium,
MPP+) are involved in the development of PD. However, although the neurotoxic effect
of such compounds has been widely reported using in vivo and in vitro experimental
approaches, their direct effect on the glial cells remains poorly characterized. In addition,
the extent to which these toxins interfere with the immune response of the glial cells, is
also underexplored. We used mouse primary mixed glial and microglial cultures to study
the effect of MPP+ and rotenone on glial activation, in the absence and the presence
of a pro-inflammatory stimulus (lipopolysaccharide plus interferon-γ, LPS+IFN-γ). We
determined the mRNA expression of the effector molecules that participate in the
inflammatory response (pro-inflammatory cytokines and enzymes), as well as the nitric
oxide (NO) and cytokine production. We also studied the phagocytic activity of the
microglial cells. In addition, we evaluated the metabolic changes associated with the
observed effects, through the measurement of adenosine triphosphate (ATP) production
and the expression of genes involved in the control of metabolic pathways. We observed
that exposure of the glial cultures to the neurotoxins, especially rotenone, impaired the
pro-inflammatory response induced by LPS/IFN-γ. MPP+ and rotenone also impaired
the phagocytic activity of the microglial cells, and this effect was potentiated in the
presence of LPS/IFN-γ. The deficit in ATP production that was detected, mainly in
MPP+ and rotenone-treated mixed glial cultures, may be responsible for the effects
observed. These results show that the response of glial cells to a pro-inflammatory
challenge is altered in the presence of toxins inhibiting mitochondrial respiratory chain
Abbreviations: ATP, adenosine triphosphate; BSA, bovine serum albumin; (COX-2), cyclooxygenase-2; Carkl, carbohydrate
kinase-like protein; CNS, central nervous system; Glut, glucose transporter; gp91phox, NADPH oxidase, catalytic subunit;
Hif, hypoxia-inducible factor; Hk, hexokinase; IL, interleukin; IFN-γ, interferon-γ; iNOS, inducible nitric oxide synthase;
LPS, lipopolysaccharide; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MTT,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NO, nitric oxide; PBS, Phosphate-buffered saline; PCR,
polymerase chain reaction; PFK-P, phosphofructokinase; PI, propidium iodide; PD, Parkinson’s disease; qRT-PCR,
quantitative real time PCR; Rot, rotenone; TNF, tumor necrosis factor.
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activity, suggesting that the glial immune response is impaired by such agents. This may
have relevant consequences for brain function and the central nervous system’s (CNS’s)
response to insults.
Keywords: glial activation, mixed glia, microglia, immune response, MPP+, rotenone, glial metabolism,
Parkinson’s disease
INTRODUCTION
Microglia are the main endogenous immune cells of the
central nervous system (CNS). Under physiological conditions,
they constantly patrol the CNS parenchyma, ready to detect
alterations that could interfere with normal brain function.
In response to noxious stimuli, microglial cells develop a
wide range of reactive phenotypes aimed at re-establishing
cerebral homeostasis and minimizing neuronal damage. In this
way, they can respond to alterations in the CNS homeostasis
due to the presence of exogenous pathogens or anomalous
protein aggregates resulting from pathological processes. In
addition, they are also able to respond to neuronal damage
resulting from brain lesions, brain ischemia, neurodegenerative
diseases or exposure to neurotoxic agents (Salter and Stevens,
2017).
In fact, exposure to neurotoxic agents, such as
pesticides, may contribute to the development of some
neurodegenerative diseases (Mostafalou and Abdollahi,
2013). In 1982, the accidental exposure to 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) in drug abusers
caused parkinsonism (Langston et al., 1983). Epidemiological
studies show that exposure to the pesticides rotenone and
paraquat, which are functional and structural analogs of MPTP
respectively, as well as to other pesticides, is a risk factor for
Parkinson’s disease (PD; Tanner et al., 2011; Goldman, 2013;
Kamel, 2013). MPTP and its analogs are inhibitors of the
mitochondrial respiratory chain and it has been suggested
that mitochondrial dysfunction is involved in the induction of
oxidative damage in dopaminergic neurons in parkinsonism
(Dauer and Przedborski, 2003; Goldman, 2013). Due to the
particular sensitivity of dopaminergic neurons to the effect
of these neurotoxins, experimental models of PD have been
developed by exposing neuronal cell cultures or laboratory
animals to these agents (Bové and Perier, 2012). These
experimental models are useful for studying mechanisms of
dopaminergic neuronal cell degeneration and testing potential
therapeutic approaches. However, although the toxic effect of
MPTP [or its active metabolite 1-methyl-4-phenylpyridinium
(MPP+)] and rotenone on dopaminergic neurons has been
widely described using both in vivo and in vitro approaches,
reports of their direct effect on glial cells are scarce. In
addition, there is some controversy regarding the results already
obtained. Either no direct effect of MPP+ on microglial cell
function (Gao et al., 2003; Jin et al., 2012), or an increase in
the expression of pro-inflammatory markers in microglial
cells after MPP+ exposure (Bournival et al., 2012; Chen
et al., 2015) has been reported. Similarly, either an increase
in the expression of pro-inflammatory factors (Gao et al.,
2013; Yuan et al., 2013; Du et al., 2014) or no direct effect
on the production of inflammatory factors (Klintworth et al.,
2009) has been observed in rotenone-treated microglial cell
cultures.
Since reciprocal communication exists in the CNS between
neuronal and glial cells, alterations in neuronal function may
affect glial function and vice versa. In fact, a possible role
of glial activation in the development of neuronal damage
in neurodegenerative diseases has been repeatedly proposed
(Perry et al., 2010; Colonna and Butovsky, 2017). In addition,
communication also exists between glial cells, and alterations
in a given cell type may affect the function of other glial
cell types. Consequently, alterations in glial function due to
exposure to neurotoxic compounds merit study, especially
in the context of neurodegenerative diseases in which such
exposure is considered a risk factor. The aim of this study
was therefore to characterize the effects of MPP+ and rotenone
on glial activation using primary mixed glial cultures, (mainly
composed of astrocytes and microglia) and microglial cultures.
We determined the direct effect of these neurotoxins on
glial cell function, and also whether they could interfere
with glial activation induced by a classical pro-inflammatory
stimulus such as lipopolysaccharide (LPS)/interferon-γ (IFN-γ).
We observed that MPP+ and rotenone did not induce the
expression of pro-inflammatory markers by glial cells per se.
However, the LPS/IFN-γ-induced pro-inflammatory response
was modified in glial cultures in the presence of MPP+ and
rotenone. These neurotoxins induced modifications in the
mRNA expression of pro-inflammatory genes and phagocytic
activity. Alterations in adenosine triphosphate (ATP) production
could account for the effects observed. These results show
that insults affecting the metabolic activity of glial cells, result
in an altered immune response, which may have relevant
consequences for normal brain function and the CNS response
to insults.
MATERIALS AND METHODS
Experiments were carried out in accordance with European
Union directives (86/609/EU) and Spanish regulations (BOE
67/8509-12, 1988) on the use of laboratory animals, and were
approved by the Ethics and Scientific Committees of the
University of Barcelona and CSIC.
Cell Cultures
Primary mixed glial cultures were prepared from the cerebral
cortex of 1–3-day old C57Bl/6 mice as previously described
(Gresa-Arribas et al., 2010). The culture medium used was
the Dulbecco’s modified Eagle medium-F12 nutrient mixture
(GIBCO) supplemented with 10% heat-inactivated fetal bovine
serum (FBS, Invitrogen, Molecular Probes, Eugene, OR, USA),
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20 U/mL penicillin-20 µg/mL streptomycin (Invitrogen), and
0.5 µg/mL amphotericin B (Fungizoner, Invitrogen). The cells
were seeded at a density of 3.5 × 105 cells/mL (100 µL, 300 µL
and 2.5 mL per well into 96-, 48- and 6-well culture plates)
and cultured at 37◦C in a humidified 5% CO2 atmosphere. The
medium was replaced once a week. The cultures were used at
21 DIV.
Primary microglia enriched cultures were obtained from
21 DIVmixed glial cultures using themild trypsinizationmethod
as previously described (Saura et al., 2003). Microglia enriched
cultures were used 24 h after isolation by this procedure.
Cell Culture Treatments
LPS and IFN-γ treatment: Cells were treated with 100 ng/ml
LPS (E. coli 026:B6, Sigma-Aldrich, St. Louis, MO, USA) and
0.1 ng/ml IFN-γ (Sigma-Aldrich) for 6 h or 24 h. Stock solutions
of 1 mg/mL LPS in a serum-free culture medium and 10 µg/mL
IFN-γ in a serum-containing culturemedium, were prepared and
stored at−20◦C.
MPP+ and rotenone treatment: Cells were treated with 10, 25,
50 and 100 µMMPP+ or 20, 40, 100 and 150 nM rotenone (both
from Sigma-Aldrich) for 6 h or 24 h, in the absence or presence of
LPS/IFN-γ. Stock solutions of 50 mMMPP+ in milliQ H2O and
10 mM rotenone in DMSO were freshly prepared on the day of
treatment. DMSO in the cell cultures was always below 1/1,000.
Treatments were added directly to the culture medium.
Nitric Oxide Production
Nitric oxide (NO) production was estimated from the nitrite
accumulation in the culture supernatant using the colorimetric
Griess reaction. Briefly, the culture supernatant from the glial
cells seeded into 96-well culture plates, was collected 24 and
48 h after treatments and stored at −20◦C until used. Fifty
microliter aliquots of the culture supernatant were incubated
with equal volumes of the Griess reagent for 10 min at 20–25◦C.
Optical density at 540 nm was measured using a microplate
reader (Multiskan Spectrum, Thermo Fisher Scientific, Vantaa,
Finland). Nitrite concentration was determined from a sodium
nitrate standard curve.
Cell Viability Measurements
Glial cells seeded into 96-well culture plates were used to
estimate cell viability from the metabolic activity by a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
colorimetric assay, 24 h after treatments. Briefly, MTT (Sigma-
Aldrich) was added to the cell cultures to reach a final
concentration of 1 mg/mL. After incubation for 30 min (mixed
glial cultures) or 90 min (microglial cultures) at 37◦C, the
medium was removed and 200 µL of DMSO was added to
each well. The optical density of the resulting blue formazan
was measured at 570 nm using a microplate reader (Multiskan
Spectrum, Thermo Fisher Scientific). Readings were taken at
650 nm to obtain background levels. Results were expressed as
percentages of the control.
Propidium iodide (PI) and Hoechst labeling were performed
to corroborate data obtained in the MTT assay. Briefly, cells
were incubated with PI (7.5 µg/ml, Molecular Probes, Eugene,
OR, USA) and Hoechst 33342 (3 µg/ml, Molecular Probes) for
10 min. Microscopy images were obtained using an Olympus
IX70 microscope (Olympus, Okoya, Japan) and a digital camera
(CC-12, Olympus Soft Imaging Solutions GmbH, Hamburg,
Germany). The extent of cell death was calculated from the
ratio between PI positive nuclei, corresponding to dead cells, vs.
Hoechst positive total nuclei.
RNA Extraction and Quantitative Real Time
PCR
Glial cells seeded into six-well culture plates were used (one
or two wells per experimental condition for mixed glia and
microglia, respectively) to assess the mRNA expression of
pro-inflammatory markers by quantitative real time polymerase
chain reaction (PCR) 6 h after treatments. A High Pure
RNA Isolation Kit (Roche Diagnostics Scheiwz AG, Rotkreuz,
Switzerland) was used to isolate the total RNA from the mixed
glial cultures. A PureLink RNA micro kit (Invitrogen) was used
to isolate the total RNA from the primary microglial cultures.
The RNA (0.5–1 µg) was reverse transcribed with random
primers using the Transcriptor Reverse Transcriptase Kit (Roche
Diagnostics). Three nanograms of cDNA were used to perform
quantitative real time PCR (qRT-PCR) with the IQ SYBRGREEN
SuperMix (Bio-Rad Laboratories, Hercules, CA, USA) using an
iCycler MyIQ apparatus (Bio-Rad Laboratories) as previously
described (Dentesano et al., 2014). The primers used (Integrated
DNA Technology, IDT, Skokie, IL, USA) are shown in Table 1.
Samples were run for 40 cycles (95◦C for 15 s, 60◦C for 30 s, and
72◦C for 15 s). The amplification specificity was confirmed by
the analysis of melting curves. Relative gene expression values
were calculated using the ∆∆Ct method (Livak and Schmittgen,
2001). β-Actin and 18S ribosomal RNA (Rn18s) were used as the
reference genes.
ELISAs
The interleukin (IL) 1β, IL6 and tumor necrosis factor α (TNFα)
release in the culture supernatant was determined using ELISA
kits specific for each cytokine (mouse IL1-β ELISA Ready-SET-
GO!, mouse IL6 ELISA Ready-SET-GO! andmouse TNFα ELISA
Ready-SET-GO!, eBioscience-Affimetrix, Inc., San Diego, CA,
USA), following the manufacturer’s instructions. The culture
supernatant from 48-well culture plates was collected 24 h after
treatments and stored at −80◦C until use. IL1β, IL6 and TNFα
concentrations were determined from the standard curves.
Phagocytosis Assay
The phagocytic activity of the microglial cells was assessed 24 h
after treatments. Briefly, the microglial cell cultures in 48-well
plates were incubated for 1 h at 37◦C with fluorescent latex
beads (FluoSpheres, carboxylate-modifiedmicrospheres, 2.0µm,
red fluorescent (580/605), 2% solids; Thermofisher Scientific;
1/1,000) 23 h after treatments. Then, the cells were washed three
times with a phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde for 15 min.
Immunocytochemistry was performed using a rabbit
polyclonal anti-Iba1 primary antibody (1/500, WAKO; Japan),
a specific marker for microglial cells. Cells were first incubated
with 0.3% Triton-X-100 in PBS containing 1% bovine serum
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TABLE 1 | Primers used for quantitative real time polymerase chain reaction (qRT-PCR).
Target mRNA Accession number Forward primer (5′→3′) Reverse primer (5′→3′)
Carkl NM_029031.3 CAGGCCAAGGCTGTGAAT GCCAGCTGCATCATAGGACT
COX2 NM_011198.4 TGCAGAATTGAAAGCCCTCT CCCCAAAGATAGCATCTGGA
Glut1 NM_011400.3 CATCCTTATTGCCCAGGTGTTT GAAGATGACACTGAGCAGCAGA
gp91phox NM_007807.5 ACTCCTTGGGTCAGCACTGGCT GCAACACGCACTGGAACCCCT
Hifα NM_010431.2 ACAAGTCACCACAGGACAG AGGGAGAAAATCAAGTCG
Hk1 NM_010438.3 GATGGAGGTGAAGAAGAAGC GGAAACGAGAAGGTGAAGC
Hk2 NM_013820.3 CGGTACACTCAATGACATCC GTAGACAGAGCCATCCACG
IL1β NM_008361.4 TGGTGTGTGACGTTCCCATTA CAGCACGAGGCTTTTTTGTTG
IL6 NM_031168.2 CCAGTTTGGTAGCATCCATC CCGGAGAGGAGACTTCACAG
iNOS NM_010927.3 GGCAGCCTGTGAGACCTTTG GCATTGGAAGTGAAGCGTTTC
Pfkp NM_019703.4 AAGCTATCGGTGTCCTGACC TCCCACCCACTTGCAGAAT
TNFα NM_013693.3 TGATCCGCGACGTGGAA ACCGCCTGGAGTTCTGGAA
Reference genes:
β-Actin NM_007393.5 CAACGAGCGGTTCCGATG GCCACAGGATTCCATACCCA
Rn18s NR_003278.3_ GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG
β-Actin, Actin, beta; Carkl, sedoheptulokinase; COX2, cyclooxygenase-2; Glut1, Glucose transporter 1; gp91phox, catalytic subunit of NAPH oxidase; Hifα, hypoxia inducible factor 1,
alpha subunit; Hk1, hexokinase 1, Hk2, hexokinase 2; IL1β, interleukin 1, beta; IL6, interleukin 6; iNOS, inducible nitric oxide synthase; Pfkp, phosphofructokinase, platelet; TNFα, tumor
necrosis factor alpha; Rn18s, 18S ribosomal RNA.
albumin (BSA) and 10% normal donkey serum for 20 min at
room temperature, and then overnight at 4◦C with the primary
antibody. Once they had been rinsed in PBS, cells were incubated
for 1 h at room temperature with an ALEXA 488 donkey
anti-rabbit secondary antibody (1/1,000; Invitrogen). Antibodies
were diluted in 0.3% Triton X-100 in PBS containing 1% BSA
and 10% normal donkey serum.
Images of three microscopic fields using a 20× objective
were obtained with an Olympus IX70 fluorescence microscope
and a digital camera (CC-12, Olympus Soft Imaging Solutions
GmbH). Two to three wells per experimental condition were
processed and each experimental condition was repeated at
least four times. Visual counting of the FluoSpheres was
performed. The percentage of phagocytic cells and the average
number of fluorescent microspheres per microglial cell were
calculated. To further characterize the phagocytic activity,
we also calculated the percentage of cells showing lower
phagocytic activity (microspheres/cell) than the controls and the
percentage of cells showing higher phagocytic activity than the
controls.
ATP Production
The intracellular production of ATP was determined using a
luminescence assay kit (ATPlite Luminescence ATP Detection
Assay System, PerkinElmer, Waltham, MA, USA) following
the manufacturer’s instructions. Briefly, cells in 96-well plates
(mixed glia) or 6-well-plates (microglia) were lysed 24 h
after treatments and the ATP concentration was measured
based on the production of light, caused by the reaction of
the ATP with added luciferase and D-luciferin. The emitted
light was quantified using a luminometer (Orion Microplate
Luminometer, Berthold Detection System, Germany). The ATP
concentration in the samples was calculated from an ATP
standard curve.
Data Presentation and Statistical Analysis
The results are presented as the mean + SEM. At least three
independent experiments were performed for analysis. Data
were statistically analyzed with the GraphPad Prism software.
Statistical analyses were performed using the one-way analysis
of variance (ANOVA) followed by the Newman-Keuls post-
test, and a two-way ANOVA followed by the Bonferroni
post-test. Values of p < 0.05 were considered statistically
significant.
RESULTS
Effects of MPP+ and Rotenone on Glial
Cell Viability
In a preliminary study, we performed dose-response experiments
in order to select working concentrations of MPP+ and rotenone
that did not result in significant alterations in cell viability
after 24 h exposure. We evaluated glial cell viability after
treating the mixed glial or the microglial cultures with increasing
concentrations of MPP+ (10, 25, 50 and 100 µM) or rotenone
(20, 40, 100 and 150 nM), both in the absence and in the presence
of LPS/IFN-γ, considering the MTT assay and PI staining.
In mixed glial cell cultures, MPP+ induced a concentration-
dependent decrease in MTT reduction that was accentuated in
the presence of LPS/IFN-γ (Figure 1A). On the contrary, no
alterations in MTT reduction were observed in microglial cell
cultures treated with MPP+, both in the absence and presence
of LPS/IFN-γ (Figure 1B). Rotenone-treated mixed glial cell
cultures showed a significant decrease in MTT reduction from
100 nM rotenone. In the presence of LPS/IFN-γ, there was a
significant decrease in MTT reduction even at 20 nM rotenone
(Figure 1C). As in the case of MPP+ treatments, no alterations
in MTT reduction were observed in microglial cell cultures
treated with rotenone or rotenone and LPS/IFN-γ (Figure 1D).
To determine whether the decrease in MTT reduction in MPP+
and rotenone-treated mixed glial cell cultures was due to a
decrease in metabolic activity or due to cell death, PI staining
was performed. Mixed glial cultures treated with 50 and 100 µM
MPP+ showed a significant increase in the percentage of PI
positive nuclei. This effect was accentuated in the presence
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FIGURE 1 | Effect of 1-methyl-4-phenylpyridinium (MPP+) and rotenone on glial cell viability. (A–D) MPP+ and rotenone induced alterations in
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction in the primary glial cultures. Effect of 10, 25, 50 and 100 µM MPP+ treatment for 24 h
on the mixed glial cultures (A) and microglial cultures (B), both in the absence and the presence of lipopolysaccharide (LPS)/interferon-γ (IFN-γ; L/I). Effect of 20, 40,
100 and 150 nM rotenone (Rot) treatment for 24 h on the mixed glial cultures (C) and microglial cultures (D), both in the absence and the presence of L/I. (E–H)
Percentage of propidium iodide (PI) positive nuclei in the mixed glial cultures (E) and microglial cultures (F) treated for 24 h with 10, 25, 50 and 100 µM MPP+, both
in the absence and the presence of LPS/IFN-γ (L/I). Percentage of PI positive nuclei in the mixed glial cultures (G) and microglial cultures (H) treated for 24 h with 20,
40, 100 and 150 nM rotenone (Rot), both in the absence and the presence of L/I. Bars are means ± SEM of four independent experiments. ∗p < 0.05,
∗∗p < 0.01 and ∗∗∗p < 0.001 vs. control (C); #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. L/I; &p < 0.05 vs. MPP+ or Rot alone; one-way analysis of variance
(ANOVA; repeated measures) and Newman-Keuls post-test.
of LPS/IFN-γ, and a significant increase was also detected at
25 µM MPP+ (Figure 1E). No alterations in the percentage
of PI-positive nuclei were observed in microglial cultures
treated with MPP+ (Figure 1F). In addition, no significant
increases in the percentage of PI-positive nuclei were observed in
rotenone-treated mixed glial cell cultures or microglial cultures
(Figures 1G,H), with the exception of cells treated with 100 µM
rotenone and LPS/IFN-γ.
The concentrations of 10 and 25 µM MPP+ and
40 and 100 nM rotenone were used in subsequent studies.
Representative images of the cultures in these experimental
conditions are shown in Figure 2, which corroborate the lack
of a toxic effect of the concentrations of MPP+ (Figure 2A) and
rotenone (Figure 2B) selected for further experiments.
MPP+ and Rotenone Induce Alterations in
the Expression of Pro-inflammatory Genes
in LPS/IFN-γ-Treated Primary Glial
Cultures
We next determined whether MPP+ and rotenone induced
a pro-inflammatory phenotype in primary glial cell cultures,
as well as whether they had some effect on the development
of the pro-inflammatory response induced by LPS/IFN-γ.
We determined the mRNA expression of the cytokines IL1β,
IL6 and TNFα and the enzymes inducible NO synthase (iNOS),
cyclooxygenase 2 (COX2) and gp91phox (the catalytic subunit of
NADPH oxidase), as markers of a pro-inflammatory response.
In general, MPP+ (Figure 3) and rotenone (Figure 4) treatment
did not significantly induce the mRNA expression of these
pro-inflammatory markers in the primary glial cell cultures,
although a trend towards increased expression was observed
for some mRNAs, especially in rotenone-treated mixed glial
cultures. On the contrary, 6 h after LPS/IFN-γ treatment,
the mRNA expression of all the pro-inflammatory markers
tested was clearly induced (Figures 3, 4). However, MPP+
and especially rotenone induced alterations in the pattern of
expression of these markers in LPS/IFN-γ treated cultures.
When glial cell cultures were treated with LPS/IFN-γ in the
presence of MPP+, the induction of IL1β mRNA expression
was significantly inhibited in the mixed glial and microglial
cultures (Figures 3A,B), while COX2 mRNA expression was
further increased in the mixed glial cultures (Figure 3A)
and gp91phox mRNA was induced in the microglial cultures
(Figure 3B). More importantly, rotenone exposure significantly
abrogated LPS/IFN-γ induction of the mRNA expression of
all pro-inflammatory markers in the mixed glial cultures
(Figure 4A), as well as IL1β, IL6 and COX2 mRNA expression
in microglial cultures (Figure 4B).
MPP+ and Rotenone Inhibit LPS/IFN-γ-
Induced NO and Pro-inflammatory
Cytokine Production in Primary Glial
Cultures
We also analyzed the effect of MPP+ and rotenone on NO,
IL1β, IL6 and TNFα release into the culture medium. MPP+
alone induced a decrease in NO production and an increase
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FIGURE 2 | Phase contrast images of the MPP+- and rotenone-treated primary glial cultures. Images show the appearance of the mixed glial cultures and microglial
cultures treated for 24 h with 10 and 25 µM MPP+ (A) or 40 and 100 nM rotenone (Rot; B), the working concentrations used in further studies. Bar = 200 µm.
in IL6 release into the culture medium in mixed glial cell
cultures 24 h after treatment (Figure 5A). The latter effect
was also observed in the MPP+-treated microglial cultures
(Figure 5B), as well as in the rotenone-treated mixed glial
(Figure 5C) and microglial cultures (Figure 5D). LPS/IFN-γ-
treatment clearly increased NO production in the mixed glial
cultures, and MPP+ (25 µM) and rotenone (40 and 100 nM)
significantly inhibited this effect (Figures 5A,C). Significant
NO production was not detected in the microglial cultures
treated with LPS/IFN-γ for 24 h (Figures 5B,D). However, an
increase in NO production was observed when the microglial
cultures were treated with LPS/IFN-γ for 48 h, but MPP+ and
rotenone did not modify this effect (data not shown). With
regards to cytokine release, LPS/IFN-γ-treatment resulted in
drastic increases in IL1β, IL6 and TNFα levels in the mixed
glial (Figures 5A,C) and microglial (Figures 5B,D) cultures.
MPP+ exposure (25 µM) significantly inhibited LPS/IFN-γ-
induced release of IL1β and IL6, but not TNFα, in the
mixed glia (Figure 5A), while it had no significant effect
on the production of these cytokines in the microglial cell
cultures (Figure 5B). Interestingly, rotenone (40 and 100 nM)
significantly inhibited IL1β, IL6 and TNFα release induced by
LPS/IFN-γ in both the mixed glial (Figure 5C) and microglial
cultures (Figure 5D).
MPP+ and Rotenone Treatment Inhibit the
Phagocytic Activity of Microglial Cells
We then evaluated whether MPP+ and rotenone modified
the phagocytic activity of the microglial cells, another
important parameter used to characterize the microglial
activation phenotype. Both MPP+ and rotenone treatment
showed a tendency to decrease the percentage of phagocytic
microglial cells that were statistically significant when the
cells were also treated with LPS/IFN-γ (Figure 6A). In
addition, MPP+ and rotenone treatment resulted in a
significant increase in the percentage of microglial cells
showing low phagocytic activity (number of microspheres
per cell lower than control) and a subsequent significant
decrease in the percentage of cells showing high phagocytic
activity (number of microspheres per cell higher than control;
Figure 6B). These effects were accentuated in the presence of
LPS/IFN-γ.
ATP Production Is Compromised in MPP+-
and Rotenone-Treated Glial Cell Cultures
In an attempt to better characterize the metabolic status of
the cells, we determined the intracellular ATP production in
response to MPP+, rotenone and LPS/IFN-γ treatments. In
general, ATP production was modified in the mixed glial
cultures in our MPP+ and rotenone experimental models
(p < 0.001, one-way ANOVA; Figure 7). In particular, ATP
production was significantly decreased after 25 µM MPP+
treatment (Figure 7A). On the contrary, a significant increase
in ATP production was detected in the LPS/IFN-γ-treated
mixed glial cultures, which was abrogated in the presence
of MPP+ and rotenone (Figures 7A,B). ATP production was
also modified in the microglial cultures in the MPP+ and
rotenone experimental models (p < 0.05, one-way ANOVA),
but to a lesser extent than in the mixed glial cultures
(Figures 7C,D).
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FIGURE 3 | Effect of MPP+ treatment on the mRNA expression of pro-inflammatory markers. mRNA expression of pro-inflammatory cytokines [interleukin-1β (IL-1β),
IL-6 and tumor necrosis factor-α (TNF-α)] and enzymes [inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), gp91phox] in the primary mixed glial
cultures (A) and microglial cultures (B) treated for 6 h with 10 and 25 µM MPP+, both in the absence and the presence of LPS/IFN-γ (L/I). 18S ribosomal RNA
(Rn18s) and β-actin were used as housekeeping genes. Bars are means ± SEM of four independent experiments. ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. C; #p < 0.05,
##p < 0.01 and ###p < 0.001 vs. L/I; one-way ANOVA and Newman-Keuls post-test. $p < 0.05 MPP+ alone vs. C, one-way ANOVA and Newman-Keuls post-test
only considering the L/I-free groups. This latter analysis was performed to detect whether the high values observed in the L/I group may hinder the detection of
statistical significance of the effects of MPP+ alone.
Metabolic Changes in LPS/IFN-γ-Treated
Glial Cultures: Effect of MPP+ and
Rotenone
In immune cells, the development of specific immune responses
is associated with specific metabolic changes. Increased glycolysis
and potentiation of the pentose phosphate pathway, together
with the inhibition of oxidative phosphorylation has been
reported for immune cells showing a pro-inflammatory
phenotype. We checked whether this was the case in our
glial cultures treated with LPS/IFN-γ and whether MPP+
and rotenone were able to modify it. We determined the
mRNA expression of genes encoding critical proteins for the
switch to glycolysis: glucose transporter 1 (Glut1; glucose
entrance into the cell), key glycolytic enzymes such as
hexokinase 1 (Hk1) (glycolysis initial rate limiting step) and
phosphofructokinase 1 (PFK1) (master regulator of glycolysis),
the glycolysis activator hypoxia-inducible factor 1α (Hif1α)
and carbohydrate kinase-like protein (Carkl), involved in the
control of the pentose phosphate pathway. In the microglial
cell cultures, MPP+ and rotenone alone did not modify the
expression of these genes per se (Figure 8). On the contrary,
as expected, LPS/IFN-γ treatment induced an increase in their
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FIGURE 4 | Effect of rotenone treatment on the mRNA expression of pro-inflammatory markers. mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6 and
TNF-α) and enzymes (iNOS, COX-2, gp91phox) in the primary mixed glial cultures (A) and microglial cultures (B) treated for 6 h with 40 and 100 nM rotenone (Rot),
both in the absence and the presence of LPS/IFN-γ (L/I). Rn18s and β-actin were used as housekeeping genes. Bars are means ± SEM of four independent
experiments. ∗p < 0.5, ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. control (C); #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. L/I; one-way ANOVA and Newman-Keuls post-test.
expression (Figure 8), with the exception of Carkl mRNA
(Figures 8I,J), which showed a decrease. MPP+ treatment
further increased LPS-IFN-γ-induced Glut1 mRNA expression
(Figure 8A), while rotenone inhibited LPS-IFN-γ-induced
Pfk1 (Figure 8F) and Hif1α (Figure 8H) mRNA expression.
We also evaluated the expression of these mRNAs in the
mixed glial cultures. MPP+ and rotenone alone increased
the Glut1 mRNA (Figures 9A,B), MPP+ and Hif1α mRNA
expression (Figure 9G). LPS/IFN-γ treatment inhibited the
expression of the glycolytic genes Glut1 (Figures 9A,B), Hk1
(Figures 9C,D) and Pfk1 (Figures 9E,F), as well as Carkl mRNA
expression (Figures 9I,J), and increased the expression of Hif1α
(Figures 9G,H). Rotenone inhibited LPS/IFN-γ-induced Hif1α
mRNA expression (Figure 9H).
DISCUSSION
In this study, we show that the response of glial cells to a
pro-inflammatory stimulus is modified by the neurotoxic agents
MPP+ and rotenone. MPP+ and rotenone treatment did not
induce a significant pro-inflammatory phenotype in the primary
mixed glial and microglial cultures per se. However, these
neurotoxic agents, mainly rotenone, did impair the development
of a pro-inflammatory phenotype in the LPS/IFN-γ-treated glial
cultures. This effect was observed in the absence of significant cell
death but in the presence of impaired metabolic activity.
The toxic effects of MPP+ and rotenone on neurons have
repeatedly been demonstrated using primary neuronal cultures,
with dopaminergic neurons showing the highest sensitivity to
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FIGURE 5 | Nitric oxide (NO) and pro-inflammatory cytokine production in the primary glial cell cultures treated with MPP+ and rotenone. NO production was
estimated from nitrite accumulation and IL1β, IL6 and TNFα levels were determined by ELISA in the culture medium of the MPP+-treated mixed glial (A) and
microglial (B) cultures, and the rotenone (Rot)-treated mixed glial (C) and microglial (D) cultures. The cell cultures were treated with 10 and 25 µM MPP+ or 40 and
100 nM Rot for 24 h, in the absence or in the presence of LPS/IFN-γ (L/I). Bars are means ± SEM of four independent experiments. ∗p < 0.5, ∗∗p < 0.01 and
∗∗∗p < 0.001 vs. control (C); #p < 0.05, ##p < 0.01 and ###p < 0.001 vs. L/I; one-way ANOVA and Newman-Keuls post-test. $p < 0.05, $$p < 0.01 and
$$$p < 0.001 MPP+ and Rot alone vs. C, one-way ANOVA and Newman-Keuls post-test only considering the L/I-free groups. This latter analysis was performed to
detect whether the high values observed in the L/I group may hinder the detection of a statistical significance of the effects of MPP+ and Rot alone.
the toxic effects of these compounds. In mouse primary cultures,
dopaminergic neuron death is observed at concentrations from
0.1 µM MPP+ (1-week exposure; Kinugawa et al., 2013) or 3
µM MPP+ (48 h exposure; Henze et al., 2005), and 10 nM
(1-week exposure; Gao et al., 2003) or 5 nM rotenone (48 h
exposure; Radad et al., 2006). Exposure to higher concentrations
of these neurotoxins is necessary to induce the death of
non-dopaminergic neurons (Gao et al., 2003; Henze et al.,
2005). The presence of microglial cells in neuronal cultures
has been associated to the increased neurotoxicity of MPP+
and rotenone (Gao et al., 2002, 2003; Emmrich et al., 2013;
Kinugawa et al., 2013). However, as MPP+- and rotenone-
damaged neurons induce reactive microgliosis, which has a
neurotoxic effect, it is difficult to establish the contribution of
a direct effect of the toxins on glial cells in the neurotoxicity
observed. In fact, although the neurotoxic effect of MPP+ and
rotenone has been widely described using in vivo and in vitro
experimental approaches, their direct effects on glial cells remain
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FIGURE 6 | Effect of MPP+ and rotenone treatment on the microglial cell phagocytosis in the primary microglial cell cultures. Phagocytic activity was evaluated
through the ingestion of fluorescent microspheres after treating the cell cultures with 10 and 25 µM MPP+ or 40 and 100 nM rotenone (Rot) for 24 h, in both the
absence and presence of LPS/IFN-γ (L/I). Internalization of microspheres was quantified after immunofluorescence labeling of the microglial cells using an anti-Iba1
antibody. (A) Percentage of cells with microspheres. Bars are means ± SEM of four independent experiments. ∗p < 0.05 and ∗∗p < 0.01 vs. control (C); one-way
ANOVA and Newman-Keuls post-test. (B) Percentage of cells with low phagocytic activity (number of microspheres/cell < C) and cells with high phagocytic activity
(number of microspheres/cells > C). Bars are means ± SEM of four independent experiments. ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. corresponding C;
#p < 0.05 and ##p < 0.01 vs. low-phagocytic cells; two-way ANOVA and Bonferroni post-test.
poorly characterized (Gao et al., 2003; Klintworth et al., 2009;
Bournival et al., 2012; Du et al., 2014; Chen et al., 2015; Zhou
et al., 2016). Most of the studies performed until now using
glial cell cultures have tested whether these neurotoxins induce
a pro-inflammatory phenotype in the microglial cells, and the
results obtained are controversial. The range of concentrations
used in these studies are higher than that used in neuronal
cultures (0.1–500 µM MPP+ and 10 nM-1 µM rotenone; Gao
et al., 2003; Henze et al., 2005; Klintworth et al., 2009; Bournival
et al., 2012; Jin et al., 2012; Du et al., 2014). Some authors have
reported no alterations (Klintworth et al., 2009; Ferger et al.,
2010; Jin et al., 2012), but others have shown the induction of
pro-inflammatory markers in the MPP+- and rotenone-treated
microglial cultures (Du et al., 2014; Zhang et al., 2014; Liang et al.,
2015; Zhou et al., 2016). Differences in the pattern of neurotoxin
treatment (concentration and duration of the treatment) and the
cell types used (primary cultures and cell lines from different
species) may partially account for the differences observed. Most
studies have considered microglial cell lines, while studies using
primary microglial cultures are scarce. In this study, we show
that concentrations of MPP+ and rotenone that did not affect
cell viability in primary glial cultures at 24 h did not result
in the induction of a significant pro-inflammatory phenotype
(with the exception of IL6 production), but they interfered
with the development of the pro-inflammatory phenotype
induced by LPS/IFN-γ. Thus, MPP+ and rotenone inhibited
pro-inflammatory cytokine production induced by LPS/IFN-γ in
glial cells (IL1β in the case of MPP+, and also IL6 and TNFα
in the case of rotenone). They also modified the expression of
pro-inflammatory enzymes (iNOS, COX2 and/or gp91phox). In
general, the alterations observed were more pronounced in the
mixed glia than in the microglial cell cultures. In addition, the
effect of rotenone was stronger than that of MPP+, although the
concentrations of rotenone used were three orders of magnitude
below those of MPP+. MPP+ and rotenone treatment also
interfered in the phagocytic activity of the microglial cells, which
was clearly inhibited after neurotoxin treatment, especially in
the presence of LPS/IFN-γ. Altogether, these results suggest
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FIGURE 7 | Adenosine triphosphate (ATP) production in the primary glial cell cultures treated with MPP+ and rotenone. Intracellular ATP production was determined
in the mixed glial cultures and microglial cultures treated with 10 and 25 µM MPP+ (A,B) or 40 and 100 nM rotenone (Rot; C,D) for 24 h, in the absence and in the
presence of LPS/IFN-γ (L/I). Bars are means ± SEM of five independent experiments. ∗p < 0.5, ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. control (C); #p < 0.05,
##p < 0.01 and ###p < 0.001 vs. L/I; &p < 0.05 and &&p < 0.01 vs. MPP+ or Rot alone; one-way ANOVA and Newman-Keuls post-test.
that MPP+ and rotenone directly impair the ability of the glial
cells to respond to a pro-inflammatory insult. In this sense,
exposure to stimuli that affect the mitochondrial activity, such
as hypoxia or respiratory chain inhibitors, has been suggested
to alter the immune response of macrophages (Wiese et al.,
2012).
At the cellular level, the main target of both MPP+ and
rotenone is the mitochondrial electron transport chain, where
they selectively inhibit complex I (Dauer and Przedborski, 2003).
As a consequence, ATP production is compromised, O−2 levels
increase, and subsequent oxidative stress occurs. This is critical
in neuronal cells, where energy production depends mainly on
ATP synthesis through oxidative phosphorylation (reviewed in
Bélanger et al., 2011). In contrast, astrocytes are mainly glycolytic
(reviewed in Bélanger et al., 2011). In addition, astrocytes can
generate lactate from glycogen via glycolysis under metabolic
activation (Hertz et al., 2007). Macrophages/microglia have the
capacity to generate ATP by both glycolytic and oxidative
pathways (although in the case of microglial cells the field is still
underexplored; Van den Bossche et al., 2017; Ghosh et al., 2018).
Indeed, they are able to shift from oxidative phosphorylation
to aerobic glycolysis (production of lactate in the presence of
oxygen) to obtain ATP from different pathways according to the
metabolic demands of their activation status (Haschemi et al.,
2012; Galván-Peña and O’Neill, 2014; Orihuela et al., 2016).
The classical activation or M1/pro-inflammatory phenotype is
associated with inhibition of the respiratory chain and the
potentiation of aerobic glycolysis, which results in more rapid
ATP production to satisfy themetabolic demands associated with
the quick pro-inflammatory response of the M1 phenotype. In
this situation, the glycolytic and pentose phosphate pathways
are potentiated, and oxidative phosphorylation is inhibited
(Haschemi et al., 2012). A metabolic-epigenetic crosstalk
is suggested to control macrophage activation (Baardman
et al., 2015). In contrast, pro-inflammatory stimuli increase
tricarboxylic acid activity in astrocytes (Gavillet et al., 2008).
In mixed glial cultures, LPS/IFN-γ treatment increased ATP
production, an effect that was clearly inhibited by MPP+ and
rotenone. These results suggest that MPP+- and rotenone-
treated cultures suffer metabolic stress that is aggravated when
the cells increase their energetic demands after LPS/IFN-γ
treatment. Consequently, activated glial cells may not fulfill their
Frontiers in Molecular Neuroscience | www.frontiersin.org 11 January 2019 | Volume 11 | Article 479
Rabaneda-Lombarte et al. Neurotoxins Impair Glial Immune Response
FIGURE 8 | Effect of MPP+ and rotenone treatment on the expression of
genes involved in the control of the glycolysis in the microglial cell cultures.
mRNA expression of the glucose transporter (Glut1; A,B) and the glycolytic
enzymes hexokinase 1 (Hk1; C,D) and phosphofructokinase 1 (Pfk1; E,F), as
well as Hif1α (G,H) and carbohydrate kinase-like protein 1 (Carkl; I,J). The
primary microglial cultures were treated for 6 h with 10 and 25 µM MPP+ or
40 and 100 nM rotenone (Rot), both in the absence and the presence of
LPS/IFN-γ (L/I). Rn18s and β-actin were used as housekeeping genes. Bars
are means ± SEM of four independent experiments. ∗p < 0.05,
∗∗p < 0.01 and ∗∗∗p < 0.001 vs. control (C); #p < 0.05 and ##p < 0.01 vs. L/I;
one-way ANOVA and Newman-Keuls post-test.
FIGURE 9 | Effect of MPP+ and rotenone treatment on the expression of
genes involved in the control of glycolysis in the mixed glial cell cultures.
mRNA expression of the glucose transporter Glut1 (A,B) and the glycolytic
enzymes Hk1 (C,D) and Pfk1 (E,F), as well as Hif1α (G,H) and Carkl (I,J). The
primary mixed glial cultures were treated for 6 h with 10 and 25 µM MPP+ or
40 and 100 nM rotenone (Rot), both in the absence and the presence of
LPS/IFN-γ (L/I). Rn18s and β-actin were used as housekeeping genes. Bars
are means ± SEM of four independent experiments. ∗p < 0.05,
∗∗p < 0.01 and ∗∗∗p < 0.001 vs. control (C); #p < 0.05 vs. L/I; one-way
ANOVA and Newman-Keuls post-test.
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metabolic demands in the presence of MPP+ and rotenone,
which would explain why mixed glial cultures exposed to
these toxicants were not able to produce an appropriate
pro-inflammatory response to LPS/IFN-γ. The effects of MPP+
and rotenone on ATP production were less drastic in the
LPS-IFN-γ-treated microglial than the mixed glial cultures.
ATP production was not significantly compromised in the
LPS/IFN-γ-treated microglial cultures exposed to MPP+ and
rotenone, with the exception of 25 µM MPP+ treatment.
In addition, the response to LPS/IFN-γ was also impaired,
to a lesser extent, in the microglial cultures than in the
mixed glial cultures. Altogether, these results suggest that the
microglial cells can better cope with the metabolic alterations
induced by MPP+ and rotenone than astrocytes can, which
accounts for 75% of the cells in the mixed glial cultures. A
possible explanation is that while microglial cells developing
a pro-inflammatory phenotype switch to glycolysis (Haschemi
et al., 2012; Galván-Peña and O’Neill, 2014; Orihuela et al.,
2016), astrocytes exposed to pro-inflammatory stimuli increase
the activity of the tricarboxylic acid cycle (Gavillet et al., 2008),
which in the presence of MPP+ and rotenone will encounter
truncated oxidative phosphorylation. However, the involvement
of a differential response of the activated microglial cells to the
toxins in the presence of astrocytes (or impaired astrocytes)
cannot be ruled out.
To assess whether the glycolytic switch mentioned above
was behind the ATP production in activated glial cultures, we
evaluated the expression of genes encoding critical proteins for
the glycolytic pathway. In the microglial cultures, a switch to
the glycolytic pathway in the LPS/IFN-γ-activated microglial
cultures was suggested by the observed increase in the expression
of Glut1, HK1, Pfk1 and Hif1α mRNA and the decreased
expression of the Carkl mRNA. Increased expression of the
glucose transporter Glut1 may result in more glucose uptake,
while the increased expression of Hk1 and Pfk1, which
regulate critical steps in glycolysis, may increase the glycolytic
rate. It has been suggested that Hif activation contributes to
macrophage polarization, and that Hifα-dependent glycolysis
favors polarization to a M1 phenotype (Palazon et al., 2016;
Taylor et al., 2016). In addition, metabolic intermediates such
as succinate play a role in Hif1α stabilization and subsequent
IL1β expression in LPS-treated macrophages (Tannahill et al.,
2013). Inhibition of the Carkl expression potentiates the flux
through the pentose phosphate pathway (Haschemi et al., 2012).
Whereas MPP+ exposure resulted in a further increase in
Glut1 expression in the LPS/IFN-γ-treated microglial cultures,
rotenone exposure partially inhibited the LPS/IFN-γ-induced
Pfk and Hifα mRNA expression. Consequently, in the case of
microglial cultures, the attenuated pro-inflammatory response
to LPS-IFN-γ mostly observed in the presence of rotenone may
result from some alterations to the glycolytic switch. In addition,
it cannot be ruled out that ATP production through oxidative
phosphorylation may also partially contribute to the energy
demand required to develop a pro-inflammatory response, even
in situations where the switch to glycolysis occurs. In this sense,
Wang et al. (2018) showed that 2-deoxyglucose, which blocks
glycolysis and partially inhibits glycolytic-dependent oxidative
phosphorylation, has a stronger inhibitory effect on the IFN-γ-
induced inflammatory response in macrophages than inhibiting
glycolysis when replacing glucose in the cell culture medium
with galactose, which reduces glycolytic flux without interfering
with oxidative phosphorylation. Interestingly, control of the
pro-inflammatory macrophage response, through metabolic
reprogramming, has been suggested as a potential therapeutic
strategy to promote remission in chronic inflammatory diseases
(Mills and O’Neill, 2016).
We observed contrasting effects in the LPS/IFN-γ-treated
mixed glia and microglial cultures in terms of the mRNA
expression of the glycolytic enzymes Glut1, Hk1, and Pfk1.
Their expression was inhibited in the mixed glia, suggesting the
contribution of astrocytes to the effects observed. Although
astrocytes are mainly glycolytic (Bélanger et al., 2011),
pro-inflammatory stimuli increase tricarboxylic acid activity
in astrocytes (Gavillet et al., 2008). The decreased expression
of the glycolytic enzymes we observed may reflect this switch.
Consequently, the impaired response of the mixed glial cultures
to LPS/IFN-γ in the presence of MPP+ and rotenone may be
explained by the fact that oxidative phosphorylation, which
would be responsible for the main ATP production from
products of the tricarboxylic acid cycle, is inhibited by MPP+
and rotenone. However, the involvement of the microglial cells
in the response of the mixed glial cultures to MPP+ and rotenone
plus LPS/IFN-γ cannot be ruled out.
Finally, some studies show that MPP+ causes DNA damage
(Zhang et al., 1995) and oxidative DNA damage in neuronal cells
(Chen et al., 2005). In addition, rotenone-induced DNA damage
(Goswami et al., 2016) and DNA methylation (Scola et al., 2014)
in neurons have also been described. Although there are no
reports on MPP+- and rotenone-induced DNA alterations on
glial cells, we cannot discard that these alterations may be behind
the decreased expression of inflammatory markers we detected
in LPS/IFN-γ–treated glial cultures exposed to the neurotoxins.
CONCLUSION
In summary, the results of the present study show that the
pro-inflammatory response induced by LPS/IFN-γ in mouse
primary glial cell cultures, is impaired underMPP+ and rotenone
exposure, mainly when both the astrocytes and microglia are
present. This suggests that the immune response of the glial
cells is compromised in the presence of neurotoxins that
inhibit the mitochondrial electron transport chain. We are
currently studying the possible effects of MPP+ and rotenone
on the development of an anti-inflammatory phenotype by the
glial cells. Although the involvement of the glial cells in the
development of neurodegenerative diseases is widely accepted,
the precise role they play in every neurodegenerative disorder
remains to be established. As many genetic and environmental
factors are probably involved in the etiopathogenesis of
neurodegenerative diseases, many factors may also determine
when and how the glial cells take part in the pathological
process. In the case of pathologies where the exposure to
certain neurotoxicants is a risk factor, such as PD, the direct
effect of the toxic agents on glial cell function may be
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an additional factor to take into account, as alterations in
glial function will have an effect on neuronal function and
CNS homeostasis. In this context, our results suggest that
glial metabolic alterations induced by neurotoxin exposure
compromises the brain’s immune response. This impaired
immune response may imply a more vulnerable brain, which
can be a further aspect contributing to the development
of PD.
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